Sign inGet started

Goldstein Michael H.

Insider CIK 1691259 · AGTC Chief Medical Officer · OCUL President, Ophthalmology & CMO

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
OCUL OCULAR THERAPEUTIX, INC A Award deriv2022-02-032022-02-07190,000— $0190,000SEC↗
OCUL OCULAR THERAPEUTIX, INC A Award2022-02-032022-02-0763,333— $0313,335SEC↗
OCUL OCULAR THERAPEUTIX, INC A Award deriv2021-02-172021-02-19250,000— $0250,000SEC↗
OCUL OCULAR THERAPEUTIX, INC A Award deriv2020-01-302020-02-03215,000— $0215,000SEC↗
OCUL OCULAR THERAPEUTIX, INC P Buy2019-05-282019-05-3012,000$2.51 $30.1K25,686SEC↗
OCUL OCULAR THERAPEUTIX, INC P Buy2019-03-152019-03-1810,000$4.15 $41.5K13,686SEC↗
OCUL OCULAR THERAPEUTIX, INC A Award deriv2019-01-022019-01-04150,000— $0150,000SEC↗
OCUL OCULAR THERAPEUTIX, INC A Award deriv2018-01-312018-02-0283,500— $083,500SEC↗
OCUL OCULAR THERAPEUTIX, INC A Award deriv2017-10-022017-10-03135,000— $0135,000SEC↗
AGTC APPLIED GENETIC TECHNOLOGI A Award deriv2017-07-172017-07-1825,000— $025,000SEC↗
AGTC APPLIED GENETIC TECHNOLOGI A Award deriv2016-12-012016-12-02180,000— $0180,000SEC↗